PRIA Logo™
LouisianaHB 7662026 Regular SessionHouseWALLET

INSURANCE/HEALTH: Provides relative to coverage for orally administered anti-cancer medications (EN +$66,367 SG EX See Note)

Sponsored By: Aimee Adatto Freeman (Democratic)

Signed by Governor

Insurance

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

2 provisions identified: 2 benefits, 0 costs, 0 mixed.

Cancer drug assistance counts toward patient costs

For covered cancer drugs, qualifying high-deductible plans must count drug-company and third-party assistance toward patient cost-sharing, deductibles, and yearly out-of-pocket limits. This includes payments, discounts, vouchers, coupons, and financial help. Insurers cannot use accumulator, maximizer, or similar programs to reduce or deny that credit. This protection covers cancer drugs in any form, but only in plans eligible for health savings accounts, medical savings accounts, or similar tax-favored programs. Federal-law limits apply, and limited-benefit policies are excluded.

Stronger cost protections for oral cancer drugs

Louisiana insurers covering cancer treatment must cover prescribed oral cancer drugs on terms no worse than injected or intravenous drugs. They cannot impose higher patient costs or stricter access rules, including prior approval or higher-cost drug tiers. Patient payments count toward deductibles and yearly out-of-pocket limits like payments for other covered benefits. Insurers can meet the coverage rule through an $80 cap per filled prescription, reduced from $100. This optional cap includes copays, coinsurance, deductibles, and other patient payments. Insurers cannot meet the rule by reclassifying or raising cancer-drug cost-sharing; increases must apply broadly to most comparable benefits. The rules cover individual, group, high-deductible, marketplace, nonfederal government, and Louisiana Office of Group Benefits plans, within federal-law limits. Limited-benefit policies are excluded, and self-funded employer plans governed by ERISA are covered only as federal law allows.

Sponsors & Cosponsors

Sponsor

  • Aimee Adatto Freeman

    Democratic • House

Cosponsors

  • Tehmi Jahi Chassion

    Democratic • House

Roll Call Votes

All Roll Calls

Yes: 255 • No: 0

House vote • 5/29/2026

Read by title, roll called, yeas 97, nays 0, Senate amendments concurred in.

Yes: 97 • No: 0

Senate vote • 5/26/2026

Rules suspended. Senate floor amendments read and adopted. Read by title, passed by a vote of 37 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.

Yes: 37 • No: 0

House vote • 5/11/2026

Read third time by title, amended, roll called on final passage, yeas 93, nays 0. Finally passed, title adopted, ordered to the Senate.

Yes: 93 • No: 0

House vote • 5/5/2026

Reported with amendments

Yes: 18 • No: 0

House vote • 4/8/2026

Reported with amendments

Yes: 10 • No: 0

Actions Timeline

  1. Signed by the Governor. Becomes Act No. 833.

    6/8/2026House

  2. Effective date: 08/01/2026.

    6/8/2026House

  3. Signed by the President of the Senate.

    6/1/2026Senate

  4. Sent to the Governor for executive approval.

    6/1/2026House

  5. Enrolled and signed by the Speaker of the House.

    5/31/2026House

  6. Read by title, roll called, yeas 97, nays 0, Senate amendments concurred in.

    5/29/2026House

  7. Scheduled for concurrence on 05/29/2026.

    5/27/2026House

  8. Rules suspended. Senate floor amendments read and adopted. Read by title, passed by a vote of 37 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.

    5/26/2026Senate

  9. Received from the Senate with amendments.

    5/26/2026House

  10. Reported without Legislative Bureau amendments. Read by title and passed to third reading and final passage.

    5/25/2026Senate

  11. Committee amendments read and adopted. Read by title and referred to the Legislative Bureau.

    5/21/2026Senate

  12. Reported with amendments.

    5/20/2026Senate

  13. Read second time by title and referred to the Committee on Insurance.

    5/13/2026Senate

  14. Received in the Senate. Read first time by title and placed on the Calendar for a second reading.

    5/12/2026Senate

  15. Called from the calendar.

    5/11/2026House

  16. Read third time by title, amended, roll called on final passage, yeas 93, nays 0. Finally passed, title adopted, ordered to the Senate.

    5/11/2026House

  17. Read by title, returned to the calendar.

    5/7/2026House

  18. Notice given.

    5/7/2026House

  19. Scheduled for floor debate on 05/11/2026.

    5/7/2026House

  20. Read by title, amended, ordered reengrossed, passed to 3rd reading.

    5/6/2026House

  21. Scheduled for floor debate on 05/07/2026.

    5/6/2026House

  22. Reported with amendments (18-0).

    5/5/2026House

  23. Read by title, amended, ordered engrossed, recommitted to the Committee on Appropriations.

    4/9/2026House

  24. Reported with amendments (10-0).

    4/8/2026House

  25. Read by title, under the rules, referred to the Committee on Insurance.

    3/9/2026House

Bill Text

Related Bills

Back to State Legislation